Namba H, Tsuchida H
Department of Anesthesiology, Sapporo Medical University School of Medicine, Japan.
Anesthesiology. 1996 Jun;84(6):1465-74. doi: 10.1097/00000542-199606000-00023.
Although halothane and isoflurane inhibit receptor agonist-induced smooth muscle contraction by inhibiting Ca2+ influx via the L-type voltage-dependent Ca2+ channels, their effects on pharmacomechanical coupling remained to be clarified. The intracellular action of both anesthetics was studied during agonist-induced contractions using the Ca2+ channel blocker verapamil.
Isolated spiral strips of rat thoracic aorta with endothelium removed were suspended for isometric tension recordings in physiologic salt solution. Cytosolic concentration of Ca2+ ([Ca2+]i) was measured concomitantly using fura-2-Ca2+ fluorescence. Muscle contraction was evoked by the receptor agonists with 30 nm norepinephrine or 10 microM prostaglandin F2 alpha (PGF2 alpha), followed by exposure to halothane, at 0%, 1%, 2%, and 3% or isoflurane, at 2% and 4%. The effects of the anesthetics were compared with those of 0.1-1 microM verapamil (n = 8 for each condition). To clarify the intracellular action of the volatile anesthetics on agonist-induced contractions, this procedure was repeated for the anesthetics only in the presence of 1 microM verapamil (n = 8 for each condition). The effects of both anesthetics were also examined in nonreceptor-mediated contractions evoked with a 1-microM dose of the protein kinase C activator, 12-deoxyphorbol 13-isobutylate, which increases the Ca2+ sensitivity of the contractile elements (n = 8 for each).
Halothane, isoflurane, and verapamil suppressed norepinephrine-and PGF2 alpha-induced increases in muscle tension and [Ca2+]i in a concentration-dependent manner. The Ca2+-tension regression lines suggested that the volatile anesthetics reduced Ca2+ sensitivity of the contractile elements during PGF2 alpha-induced contraction. Pretreatment of the muscle strip with verapamil revealed that halothane and isoflurane released Ca2+ during norepinephrine-induced contraction and that [Ca2+]i-tension relationship was modulated during PGF2 alpha-induced contractions. Halothane at 2% and 3% and isoflurane at 4% suppressed 12-deoxyphorbol 13-isobutylate-induced increases in muscle tension, whereas they enhanced increases in [Ca2+]i, indicating that both anesthetics suppressed Ca2+ sensitivity during 12-deoxyphorbol 13-isobutylate-induced contraction.
Verapamil pretreatment unmasked the intracellular action of the anesthetics. Halothane and isoflurane influenced pharmacomechanical coupling during agonist-induced contraction.
尽管氟烷和异氟烷通过抑制L型电压依赖性钙通道的钙内流来抑制受体激动剂诱导的平滑肌收缩,但其对药物 - 机械偶联的影响仍有待阐明。使用钙通道阻滞剂维拉帕米,研究了这两种麻醉剂在激动剂诱导的收缩过程中的细胞内作用。
将去除内皮的大鼠胸主动脉离体螺旋条悬于生理盐溶液中进行等长张力记录。使用fura - 2 - Ca2 +荧光同步测量细胞溶质钙浓度([Ca2 +]i)。用30 nM去甲肾上腺素或10μM前列腺素F2α(PGF2α)受体激动剂诱发肌肉收缩,随后分别暴露于0%、1%、2%和3%的氟烷或2%和4%的异氟烷。将麻醉剂的作用与0.1 - 1μM维拉帕米的作用进行比较(每种情况n = 8)。为了阐明挥发性麻醉剂对激动剂诱导收缩的细胞内作用,仅在存在1μM维拉帕米的情况下对麻醉剂重复此过程(每种情况n = 8)。还在由1μM剂量的蛋白激酶C激活剂12 - 脱氧佛波醇13 - 异丁酯诱发的非受体介导的收缩中检查了两种麻醉剂的作用,该激活剂可增加收缩元件的钙敏感性(每种情况n = 8)。
氟烷、异氟烷和维拉帕米以浓度依赖性方式抑制去甲肾上腺素和PGF2α诱导的肌肉张力和[Ca2 +]i增加。钙 - 张力回归线表明,挥发性麻醉剂在PGF2α诱导的收缩过程中降低了收缩元件的钙敏感性。用维拉帕米预处理肌肉条显示,氟烷和异氟烷在去甲肾上腺素诱导的收缩过程中释放钙,并且在PGF2α诱导的收缩过程中[Ca2 +]i - 张力关系受到调节。2%和3%的氟烷以及4%的异氟烷抑制了12 - 脱氧佛波醇13 - 异丁酯诱导的肌肉张力增加,而它们增强了[Ca2 +]i的增加,表明两种麻醉剂在12 - 脱氧佛波醇13 - 异丁酯诱导的收缩过程中均抑制了钙敏感性。
维拉帕米预处理揭示了麻醉剂的细胞内作用。氟烷和异氟烷在激动剂诱导的收缩过程中影响药物 - 机械偶联。